Med. Pro Praxi 2007; 4: 169-171 [Psychiatr. pro Praxi, 2006; 6: 285-287]

Deprese s úzkostí a poruchami spánku

MUDr. Jiřina Kosová
Psychiatrické centrum Praha, 3. LF UK, Praha

Komorbidita depresí a úzkostných poruch je velmi frekventovaná a je spíše pravidlem než výjimkou. Klasifikace úzkostných a depresivních poruch se historicky měnila podle převažujícího medicínského názoru na jejich vzájemný vztah. Společný výskyt depresivní a úzkostné poruchy znamená více perzistující průběh onemocnění se závažnějšími příznaky, pacienti jsou více hospitalizováni a častěji páchají sebevraždu. Poruchy spánku jsou integrální částí depresivních a mnoha úzkostných poruch, jsou popisovány u více než 90 % pacientů. Včasné rozpoznání a zaléčení je nutné k prevenci vzniku a zhoršování všech komorbidních symptomů a psychosociálních funkcí.

Keywords: deprese, úzkost, nespavost, komorbidita

Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kosová J. Deprese s úzkostí a poruchami spánku. Med. praxi. 2007;4(4):169-171.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arborelius L, Owens MJ, Plotsky PM, et al. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12. Go to original source... Go to PubMed...
    2. Belzer K, Schneier FR. Comorbidity of anxiety and depressive disorders: Issues in conceptualization, assessment, and treatment. J Psych Practice 2004; 10 (5): 296-306. Go to original source... Go to PubMed...
    3. Benca RM. Diagnosis and treatment of chronic insomnia: A review. Psych Services 2005; 56 (3): 332-343. Go to original source... Go to PubMed...
    4. Bittner A, Goodwin RD, Witchen HU, et al. What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry 2004; 65 (5): 618-626. Go to original source... Go to PubMed...
    5. Cassidy EL, Lauderdale S, Sheikh JI. Mixed anxiety and depression in older adults: Clinical characteristics and management. J Ger Psych Neurol 2005; 18: 83-88. Go to original source... Go to PubMed...
    6. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100: 316-336. Go to original source... Go to PubMed...
    7. Clark DA, Steer RA, Beck AT. Common and specific dimension of self-reported anxiety and depression: implications for the cognitive and tripartite models. J Abnorm Psychol 1994; 103: 645-654. Go to original source... Go to PubMed...
    8. Cortese BM, Phan KL. The role of glutamate in anxiety and related disorders. CNS Spectr 2006; 11 (1): 14-15. Go to original source...
    9. De Vane CL, Chiao E, Franklin M, Kruep EJ. Anxiety disorders in the 21st century: Status, challenges, opportunities, and comorbidity with depression. Am J Man Care 2005; 11 (Suppl. 12): S344-S353.
    10. Farabaugh A, Fava M, Mischoulon D et al. Relationships between major depressive disorder and comorbid anxiety and personality disorders. Compr Psychiatry 2005; 46 (4): 266-271. Go to original source... Go to PubMed...
    11. Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 2004; 34 (7):1299-1308. Go to original source... Go to PubMed...
    12. Fiter SK, Mathias SD, Patrick DL, et al. Untreated anxiety among adulty primary care pacients in a Health Maintenance Organization. Arch Gen Psychiatry 1994; 51: 740-750. Go to original source... Go to PubMed...
    13. Joliat MJ, Schmidt ME, Fava M, et al. Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine. J Clin Psychiatry 2004; 65 (3): 373-378. Go to original source... Go to PubMed...
    14. Kagan J, Reznick JS, Snidman N. The physiology and psychology of behavioral inhibition in children. Child Dev 1987; 58: 1459-1473. Go to original source... Go to PubMed...
    15. Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R Major Depressive disorder in general population: results from the US national comorbidity survey. Br J Psychol 1996; 168: 17-30. Go to original source...
    16. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62 (6): 617-627. Go to original source... Go to PubMed...
    17. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005; 10 (10): 808-819. Go to original source... Go to PubMed...
    18. Levine J, Chengappa KNR, Gershon S et al. Differentiating primary pathophysiologic from secondary adaptational processes. Depress Anxiety 2001; 14: 105-111. Go to original source... Go to PubMed...
    19. Lydiard RB, Brawman-Mintzer O. Anxious depresion. J Clin Psychiatry 1998; 59 (suppl 18): 10-17.
    20. Mantere O, Melartin TK, Suominen K, et al. Differences in axis I and II comorbidity between bipolar I and II disorders and major depressive disorder. J Clin Psychiatry 2006; 67 (4): 584-593. Go to original source... Go to PubMed...
    21. Maršálek M. Komorbidita úzkosti a deprese. Psychiatrie 2003; 7(3): 203-213.
    22. Muris P, Merckelbach H, Schmidt H, et al. Anxiety and depression as correlates of self-reported behavioural inhibition in normal adolescents. Behav Res Ther 2001; 39: 1051-1061. Go to original source... Go to PubMed...
    23. Nierenberg AA, Wright EC. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry 1999; 60 (suppl 22): 7-11.
    24. Noyes R, Jr. Comorbidity in generalized anxiety disorder. Psychiatr Clin North Am 2001; 24: 41-55. Go to original source... Go to PubMed...
    25. Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psych Research 2003; 37: 9-15. Go to original source... Go to PubMed...
    26. Regier DA, Rae DS, Narrow WE, et al. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998; 173 (Suppl 134): 24-28. Go to original source...
    27. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophsiology of depression and the anxiety disorders. Depress Anxiety 2000; 12 (suppl 1): 2-19. Go to original source... Go to PubMed...
    28. Reznick JS, Hegeman IM, Kaufman E, et al. Retrospective and concurrent self-report of behavioral inhibition and their relation to adult mental health. Dev Psycopathol 1992; 4: 301-321. Go to original source...
    29. Spoormaker VI, van den Bout J. Depression and anxiety complaints; relations with sleep disturbances. Eur Psychiatry 2005; 20 (3): 243-245. Go to original source... Go to PubMed...
    30. Starcevic V. Psychiatric comorbidity: concepts, controversies and alternatives. Australasian Psychiatry 2005; 13 (4): 375-378. Go to original source... Go to PubMed...
    31. Thase ME. Antidepressant treatment of the depressed patiens with insomnia. J Clin Psychiatry 1999; 60 (Suppl 17): 28-31.
    32. Thase ME. Treatment issues related to sleep and depression. J Clin Psychiatry 2000; 61 (Suppl. 11): 46-50.
    33. Thase ME. Correlates and consequences of chronic insomnia. Gen Hosp Psychiatry 2005; 27 (2): 100-112. Go to original source... Go to PubMed...
    34. Weyerer S, Dilling H. Prevalence and treatment of insomnia in the community: Results from the Upper Bavarian Field Study. Sleep 1991; 14: 392-398. Go to PubMed...
    35. Zimmerman M, Chelminski I. Screening for anxiety disorders in depressed patients. J Psych Research 2006; 40: 267-272. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.